BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 16, 2011
View Archived Issues
Novel histamine H4 receptor antagonist shows anti-inflammatory activity in vivo
Read More
FX-06 may be beneficial for renal transplant
Read More
Novo Nordisk reviews events of third quarter 2011
Read More
ProFibrix's phase II trial of Fibrocaps meets primary endpoint
Read More
AMG-145 assessed in first-in-human trial
Read More
Phase II results reported for miravirsen
Read More
PBI-4050 demonstrates nephroprotection in animal models
Read More
Chemokine as proinflammatory signal after traumatic brain injury
Read More
BIIB-023 demonstrates favorable safety and tolerability profile in rheumatoid arthritis trial
Read More
Korean scientists patent new serotonin 5-HT4 receptor agonists
Read More
Novel haspin inhibitors designed by Brigham & Women's Hospital
Read More
GSK discloses novel macrolides for inflammatory disorders
Read More
New GPR119 agonists/DPP IV inhibitors claimed
Read More
Researchers at Roche prepare new HSL inhibitors
Read More
Probiodrug's PQ-912 shows promising topline phase I results
Read More
Geron discontinues stem cell programs
Read More
TGase-2 correlated with reduced survival in lung cancer
Read More
Fujifilm and Kyowa Hakko Kirin reach agreement on biosimilars
Read More
Promising results emerge from phase I/IIa Glymera study
Read More
Takeda begins phase II TAK-361S vaccine trials in Japan
Read More
The TB Alliance and U.S. NIAID join forces to accelerate REMox TB study
Read More
ViroPharma acquires DuoCort Pharma
Read More
Almirall and Forest Labs initiate phase III program for aclidinium/formoterol combination
Read More
SymBio announces plan for new study of SyB L-0501 in multiple myeloma
Read More
Menarini to expand presence in Asia-Pacific with acquisition of Invida
Read More
AMT's gene therapy for hemophilia B given orphan drug status in Europe
Read More
European Commission approves Vectibix for expanded indications
Read More